Bloomage BioTechnology Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Yan Zhao
Chief executive officer
CN¥2.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.02% |
| Management average tenure | 4.4yrs |
| Board average tenure | 4.5yrs |
Recent management updates
No updates
Recent updates
Bloomage BioTechnology (SHSE:688363) Will Want To Turn Around Its Return Trends
Dec 13
Why Bloomage BioTechnology's (SHSE:688363) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 06After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar
Sep 30Need To Know: Analysts Just Made A Substantial Cut To Their Bloomage BioTechnology Corporation Limited (SHSE:688363) Estimates
Aug 30Bloomage BioTechnology Corporation Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 27Bloomage BioTechnology (SHSE:688363) Seems To Use Debt Quite Sensibly
Jun 02Weak Statutory Earnings May Not Tell The Whole Story For Bloomage BioTechnology (SHSE:688363)
May 06Getting In Cheap On Bloomage BioTechnology Corporation Limited (SHSE:688363) Might Be Difficult
May 01CEO
Yan Zhao (58 yo)
no data
Tenure
CN¥2,024,900
Compensation
Ms. Yan Zhao serves as the Chairwoman at Pando Group Limited. She is also the majority shareholder in and serves as Chairman and Executive Director of Bloomage BioTechnology Corporation Limited and serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥2.02m | 0.024% CN¥ 6.5m | |
| Deputy GM & Director | no data | CN¥925.30k | 0.012% CN¥ 3.1m | |
| Deputy GM of Core Technician & Director | no data | CN¥946.70k | 0.017% CN¥ 4.5m | |
| Deputy GM | no data | CN¥1.70m | no data | |
| Deputy General Manager | no data | CN¥1.82m | 0.015% CN¥ 4.0m | |
| Deputy General Manager | 5.8yrs | CN¥734.90k | 0.0092% CN¥ 2.5m | |
| Deputy General Manager | 3.8yrs | CN¥1.00m | 0.0026% CN¥ 704.7k | |
| Deputy General Manager | 5yrs | CN¥1.01m | 0.012% CN¥ 3.1m | |
| CFO & Financial Director | less than a year | no data | no data | |
| Head of Accounting & Accounting Supervisor | no data | no data | no data |
4.4yrs
Average Tenure
51yo
Average Age
Experienced Management: 688363's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥2.02m | 0.024% CN¥ 6.5m | |
| Deputy GM & Director | no data | CN¥925.30k | 0.012% CN¥ 3.1m | |
| Deputy GM of Core Technician & Director | no data | CN¥946.70k | 0.017% CN¥ 4.5m | |
| Deputy GM | no data | CN¥1.70m | no data | |
| Independent Director | 5.8yrs | CN¥150.00k | no data | |
| Independent Director | 5.8yrs | CN¥150.00k | no data | |
| Supervisor | 4.5yrs | no data | no data | |
| Employee Representative Supervisor | 4.5yrs | no data | no data | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Director | 2.7yrs | CN¥626.90k | 0.0019% CN¥ 501.8k | |
| Director | 2.7yrs | CN¥862.90k | 0.0038% CN¥ 1.0m | |
| Independent Director | 2.7yrs | CN¥150.00k | no data |
4.5yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 688363's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 02:01 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bloomage BioTechnology Corporation Limited is covered by 34 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fang Yi Cai | Changjiang Securities Co. LTD. |
| Jian Jun Zou | Chasing Securities |
| Xiyue Zhang | Chasing Securities |